InvestorsHub Logo
Followers 2
Posts 120
Boards Moderated 0
Alias Born 02/25/2012

Re: None

Wednesday, 10/01/2014 2:03:29 AM

Wednesday, October 01, 2014 2:03:29 AM

Post# of 232287
The potential to target CCL5/CCR5 in breast cancer



Expert opinion: The role of CCR5 in HIV infection led to the development of specific and potent CCR5 antagonists. The data reviewed here includes basic and translational studies that support the use of such CCR5 antagonists in breast cancer patients as adjuvant therapy to block the metastasis.


Read More: http://informahealthcare.com/doi/abs/10.1517/14728222.2014.949238
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News